phentermine and metformin

phentermine has been researched along with metformin in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (28.57)	29.6817
2010's	3 (42.86)	24.3611
2020's	2 (28.57)	2.80

Authors

Authors	Studies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Glen, RC; Lowe, R; Mitchell, JB	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Alisky, JM	1
Eid, WE	1
Bellanger, D; Chappell, N; Elkind-Hirsch, KE; Seidemann, E; Storment, J	1
Brown, JD; Donahoo, WT; Hampp, C; Sarayani, A; Winterstein, AG	1

Reviews

1 review(s) available for phentermine and metformin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for phentermine and metformin

Article	Year
Exenatide, Dapagliflozin, or Phentermine/Topiramate Differentially Affect Metabolic Profiles in Polycystic Ovary Syndrome. The Journal of clinical endocrinology and metabolism, 2021, 09-27, Volume: 106, Issue:10 Topics: Adolescent; Adult; Benzhydryl Compounds; Blood Glucose; Drug Therapy, Combination; Exenatide; Female; Glucose Tolerance Test; Glucosides; Humans; Hypoglycemic Agents; Metformin; Middle Aged; Obesity; Phentermine; Polycystic Ovary Syndrome; Prospective Studies; Single-Blind Method; Topiramate; Treatment Outcome; Weight Loss; Young Adult	2021

Article

Year

Exenatide, Dapagliflozin, or Phentermine/Topiramate Differentially Affect Metabolic Profiles in Polycystic Ovary Syndrome.

The Journal of clinical endocrinology and metabolism, 2021, 09-27, Volume: 106, Issue:10

Topics: Adolescent; Adult; Benzhydryl Compounds; Blood Glucose; Drug Therapy, Combination; Exenatide; Female; Glucose Tolerance Test; Glucosides; Humans; Hypoglycemic Agents; Metformin; Middle Aged; Obesity; Phentermine; Polycystic Ovary Syndrome; Prospective Studies; Single-Blind Method; Topiramate; Treatment Outcome; Weight Loss; Young Adult

2021

Other Studies

5 other study(ies) available for phentermine and metformin

Article	Year
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Phentermine, sibutramine and metformin could be used for the prevention and treatment of steroid-induced weight gain. Medical hypotheses, 2007, Volume: 68, Issue:2 Topics: Adrenergic Agents; Appetite Depressants; Cyclobutanes; Humans; Hypoglycemic Agents; Metformin; Phentermine; Steroids; Weight Gain	2007
Obesity and type 2 diabetes mellitus in South Dakota: focused insight into prevalence, physiology and treatment. South Dakota medicine : the journal of the South Dakota State Medical Association, 2011, Volume: Spec No Topics: Adipocytes; Adrenergic Agents; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Obesity; Phentermine; Prevalence; South Dakota; Weight Loss	2011
Topiramate Utilization After Phentermine/Topiramate Approval for Obesity Management: Risk Minimization in the Era of Drug Repurposing. Drug safety, 2022, Volume: 45, Issue:12 Topics: Anti-Obesity Agents; Atorvastatin; Drug Approval; Drug Repositioning; Female; Fructose; Humans; Male; Metformin; Obesity; Phentermine; Pregnancy; Topiramate	2022